WOMAN Trials Wrapped: Highlights from 2024
2024 has been an extremely busy year for the WOMAN Trials team. From publishing and presenting the WOMAN-2 Trial results, to planning the WOMAN-3 Trial and starting recruitment for the …
Tranexamic acid cuts life-threatening bleeding after birth, but anaemia prevention is critical, studies show
Two papers from the WOMAN Trials Collaborators, published in The Lancet today, reveal important evidence on the effects of the drug tranexamic acid (TXA) on postpartum haemorrhage (PPH) and life-threatening …
Looking ahead: What next for WHO’s roadmap to fight PPH and WOMAN Trials research to reduce maternal deaths
This article was written by the WOMAN Trials team. A year ago today, the WHO released its first roadmap to combat deaths from postpartum haemorrhage (PPH) – a condition …
Discussions on data, drafts and dissemination: The WOMAN Trials writing committee meeting
“Some of the most disadvantaged women took part in the WOMAN-2 Trial. They shared their experiences with us so that we could learn from them. “This is why we’ve been …
“Our women are different”: The link between anaemia and maternal mortality in Nigeria
In this film, LSHTM Professors Haleema Shakur-Still and Ian Roberts reflect on their late colleague Professor Bukola Fawole. While working on the WOMAN Trial, he presciently recognised the significance of …
Clinical Trials Day: Celebrating the trailblazers seeking to make childbirth safer
On 20 May, Clinical Trials Day (ICTD), we celebrate the trailblazers among us who are making an impact through their research. Trailblazers are those who power the advancement of human …
Comment: why do so many women die giving birth in Nigeria?
Written by Professor Ian Roberts, Professor of Epidemiology at LSHTM and co-lead of the WOMAN-2 Trial. I read with interest Kasia Strek’s article in the Guardian this week, “Pregnancy is …
World Health Day: Women’s basic right to health is not being upheld
Written by Professor Ian Roberts, Professor of Epidemiology at LSHTM and co-lead of the WOMAN-2 Trial. Access to quality health services is a basic human right. This is reflected in …
International Women’s Day: Why are the most vulnerable women excluded from clinical trials?
Written by Professor Ian Roberts, Professor of Epidemiology at LSHTM and co-lead of the WOMAN-2 Trial. Equality, diversity and inclusion are social justice issues at the heart of International Women’s …
Failure of the uterus or our understanding?
Written by Professor Ian Roberts, Professor of Epidemiology at LSHTM and co-lead of the WOMAN-2 Trial. On 15 January 2024, a new fact will enter the world. It will take …